Decrease in Tumor Apparent Permeability-Surface Area Product to a MRI Macromolecular Contrast Medium Following Angiogenesis Inhibition with Correlations to Cytotoxic Drug Accumulation

References

• Borgstroem P, Hillan K, Srirarnarao P, Ferrara N. (1996). Complete inhibition of angiogenesis and growth of microturnors by anti-vascular endothelial growth factor neutralizing antibody: novel concepts of angio static therapy from intravital videomicroscopy. Cancer Res 56:4032–4039.
   PubMed Web of Science ®Google Scholar
• Brasch R, Pham C, Shames D, Roberts T, van Dijke K, van Bruggen N, Mann J, Ostrowitzki S, Melnyk O. (1997). Assessing tumor angiogenesis using macro-molecular MR imaging contrast media. J Magn Reson Imaging 7:68–74.
   PubMed Web of Science ®Google Scholar
• Brasch R, Shames D, Cohen F, Kuwatsuru R, Neuder M, Mann J, Vexler V, Miihler A, Rosenau W. (1994). Quantification of capillary permeability to macro-molecular magnetic resonance imaging contrast me-dia in experimental mammary adenocarcinomas. In-vest Radiol Suppl. 2:S8—S11.
   Google Scholar
• Chabner B (1982). Pyrirnidine antagonists. In: Phar-macologic Principles of Cancer Treatment. Philadel-phia: WB, Saunders, 193–195.
   Google Scholar
• Daldrup H, Shames D, Husseini W, Wendland M, Brasch RC. (1998). Quantification of the extraction fraction for gadopentetate across breast tumor capil-laries. Magnet Reson Med 40:67–78.
   Google Scholar
• Daldrup H, Shames D,Wendland M, Okuhata Y, Link T, Rosenau W, Lu Y, Brasch RC. (1998). Correlation of dynamic contrast-enhanced magnetic resonance imaging with histologic tumor grade: comparison of macromolecular and small molecular contrast media. Am J Roentgenol 28:67–78.
   Google Scholar
• Eksborg A, Ehrsson H, Ekqvist B. (1982). Protein binding of anthraquinone glycosides with special ref-erence to adriamycin. Cancer Chemth Pharm 10:7–10.
   PubMed Web of Science ®Google Scholar
• Jain R. (1988). Determinants of tumor blood flow: a review. Cancer Res 48:2641–2658.
   Google Scholar
• Jain R. (1990). Vascular and interstitial barriers to de-livery of therapeutic agents in tumors. Cancer Metast
   Google Scholar
• Jain R.(1994). Barriers to drug delivery in solid tu-mors. Sci Am 271:58–65.
   Google Scholar
• Jain R. (1998). The next frontier of molecular medicine: delivery of therapeutics. Nat Med 4:655–657.
   Google Scholar
• Kim K, Li B, Winer J, Armanini M, Gillet N, Phillips H, Ferrara N. (1993). Inhibition of vascular endothelial growth factor-induced angiogenesis suppressor tumor
   Google Scholar
• Lee K, Erturk E, Mayer R, Cockett A. (1987). Efficacy of antitumor chemotherapy in C3H mice enhanced by the antiangiogenesis steroid, cortisone acetate. Cancer
   Google Scholar
• Manaka R, Wolf W. (1978). Distribution of cisplatin in blood. Chem-Biol Interact 22:353–358.
   PubMed Web of Science ®Google Scholar
• Melnyk O, Shuman M, Kim K. (1996). Vascular endothelial growth factor promotes tumor dissemination by a mechanism distinct from its effect on primary tumor growth. Cancer Res 56:921–924.
   PubMed Web of Science ®Google Scholar
• Ogan M, Schmiedl U, Moseley M, Grodd W, Paajenen H, Brasch RC. (1987). Albumin labeled with Gd- DTPA: an intravascular contrast enhancing agent for magnetic resonance blood pool imaging: preparation and characterization. Invest Radiol 22:665–671.
   PubMed Web of Science ®Google Scholar
• Perera A, Jackson H, Sharma H, Mc Auliffe C, Fox B. (1992). A comparative binding of platinum anti-turnor compounds to plasma proteins in the rat (in vivo) and mouse (in vitro). Chem-Biol Interact 85:199–213.
   Google Scholar
• Pharm C, Roberts T, Bruggen N, Melnyk O, Ferrara N, Cohen R, Brasch RC. (1997). Magnetic resonance imaging detects suppression of tumor vascular per-meability after administration of antibody to vascular endothelial growth factor. Cancer Invest 16:225–230.
   Google Scholar
• Prato F, Wisenberg G, Marshall T, Uksik P, Zabel P. (1988). Comparison of the biodistribution of gadolinium-153 DTPA and technetium-99m DTPA in rats. J Nucl Med 29:1683–1687.
   PubMed Web of Science ®Google Scholar
• Price J, Polyzos A, Zhang R, Daniels L. (1990). Tu-morigeneicity and metastasis of human breast carci-noma cell lines in nude mice. Cancer Res 50:717–721.
   PubMed Web of Science ®Google Scholar
• Shames D, Kuwatsuru R, Vexler V, Muehler A, Brasch R. (1993). Measurement of capillary permeability to macromolecules by dynamic magnetic resonance imaging: a quantitative non-invasive technique. Mag-net Reson Med 29:616–622.
   PubMed Web of Science ®Google Scholar
• Teicher B, Sotomayor E, Huang Z. (1992). Antian-giogenic agents potentiate cytotoxic cancer therapies against primary and metastatic disease. Cancer Res 52:6702–6704.
   PubMed Web of Science ®Google Scholar
• Toi M, Kondo S, Suzuki H, Yamamoto Y, Inada K, Imazawa T, Taniguchi T, Tominaga T. (1996). Quantitative analysis of vascular endothelial growth factor in primary breast cancer. Cancer 77:1101–1106.
   PubMed Web of Science ®Google Scholar
• Wrightson W, Myers S, Galandiuk S. (1995). HPLC analysis of 5-FU and FdUMP in tissue and serum. Biochem Biophys Res Commun 216:808–813.
   Google Scholar
• Yuan F, Dellin M, Fukurnura D, Leunig M, Berk D, Torchillin V, Jain R. (1995). Vascular permeability in a human tumor xenograft: molecular size dependence and cutoff size. Cancer Res 55:3752–3756.
   PubMed Web of Science ®Google Scholar